Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 4 more changesShow less
    • Primary completion date changed from estimate of Nov 2028 to Jan 13, 2025
    • Enrollment target: estimated 20 to confirmed 19
    • Eligibility criteria expanded, about 14 words
    • Site details revised
  2. 5 versions Re-verified since Aug 14, 2020, no change to tracked fieldsv6-v10
  3. Primary and study completion dates: Nov 2018 to Nov 2028v5
  4. Primary and study completion dates: Nov 2017 to Nov 2018v4
  5. Primary and study completion dates: Nov 2016 to Nov 2017v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to see how useful the information provided from Positron Emission Tomography (PET) scans can be in the actual planning and delivery of radiation treatment to patients who have head and neck cancers. Patients participating in this study, will have (in addition to their routine tests) a PET scan before and during their radiation treatment. Following the intervention, patients will be followed as per standard practice.
Trial Details
NCT Number NCT02678884
Lead Sponsor University Health Network, Toronto
Conditions
(from sponsor)		 Head and Neck Squamous Cell Carcinoma
Related terms Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck
Enrollment 19 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov